Bioregenx (BRGX) Short-Term Debt issuances (2023 - 2024)
Bioregenx's quarterly Short-Term Debt issuances came in at -$10312.0 in Q3 2024, up 43.69% year-on-year from -$7176.7 in Q4 2023, and up 14.21% quarter-over-quarter from -$12020.0 in Q2 2024.
Bioregenx has reported Short-Term Debt issuances for 2 years, with the latest figure at -$10312.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Bioregenx | - | - | 348,288.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -10,312.00 |
| Sep 30, 2024 | -10,312.00 |
| Jun 30, 2024 | -12,020.00 |
| Jun 30, 2024 | -12,020.00 |
| Mar 31, 2024 | -17,438.00 |
| Mar 31, 2024 | -17,438.00 |
| Sep 30, 2023 | -18,312.00 |
| Sep 30, 2023 | -18,312.00 |
| Jun 30, 2023 | -177,000.00 |
| Jun 30, 2023 | -177,000.00 |